이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
보상
위험 분석
위험 검사에서 COO 에 대한 위험이 감지되지 않았습니다.
The Cooper Companies, Inc. 경쟁사
가격 내역 및 성능
과거 주가 | |
---|---|
현재 주가 | US$94.14 |
52주 최고치 | US$104.07 |
52주 최저치 | US$75.94 |
베타 | 0.98 |
11개월 변경 | 3.50% |
3개월 변경 사항 | -3.26% |
1년 변경 사항 | 2.06% |
33년 변화 | -15.22% |
5년 변화 | 17.06% |
IPO 이후 변화 | 1,120.51% |
최근 뉴스 및 업데이트
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Recent updates
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03The Cooper Companies Non-GAAP EPS of $3.19 misses by $0.04, revenue of $843.4M beats by $13.18M
Aug 31Is Now The Time To Look At Buying The Cooper Companies, Inc. (NYSE:COO)?
Aug 30Cooper Companies: The Perfect Harbor For A Perfect Storm
Aug 18Cooper Companies (NYSE:COO) Seems To Use Debt Quite Sensibly
Aug 03주주 수익률
COO | US Medical Equipment | US 마켓 | |
---|---|---|---|
7D | 1.1% | 2.7% | 3.9% |
1Y | 2.1% | 10.5% | 25.3% |
수익률 대 산업: COO 지난 1년 동안 9.3 %를 반환한 US Medical Equipment 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: COO 지난 1년 동안 24.9 %를 반환한 US 시장보다 저조한 성과를 냈습니다.
가격 변동성
COO volatility | |
---|---|
COO Average Weekly Movement | 3.0% |
Medical Equipment Industry Average Movement | 8.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.1% |
10% least volatile stocks in US Market | 3.2% |
안정적인 주가: COO 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.
시간에 따른 변동성: COO 의 주간 변동성( 3% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개
설립 | 직원 | CEO | 웹사이트 |
---|---|---|---|
1958 | 15,000 | Al White | www.coopercos.com |
쿠퍼 컴퍼니즈는 자회사와 함께 콘택트렌즈 착용자를 개발, 제조 및 판매하고 있습니다. 이 회사는 쿠퍼비전과 쿠퍼서지컬의 두 부문으로 운영되고 있습니다. 쿠퍼비전 부문은 근시 및 원시를 교정하는 렌즈를 포함한 구면 렌즈와 난시, 노안, 근시 등 시력 문제를 교정하는 렌즈로 구성된 토릭 및 다초점 렌즈를 미주, 유럽, 중동, 아프리카 및 아시아 태평양 지역에 공급합니다.
The Cooper Companies, Inc. 기본 사항 요약
COO 기본 통계 | |
---|---|
시가총액 | US$18.32b |
수익(TTM) | US$339.90m |
수익(TTM) | US$3.73b |
55.1x
P/E 비율5.0x
P/S 비율COO 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
COO 손익 계산서(TTM) | |
---|---|
수익 | US$3.73b |
수익 비용 | US$1.26b |
총 이익 | US$2.47b |
기타 비용 | US$2.13b |
수익 | US$339.90m |
최근 보고된 수익
Apr 30, 2024
다음 수익 날짜
Aug 28, 2024
주당 순이익(EPS) | 1.71 |
총 마진 | 66.23% |
순이익 마진 | 9.11% |
부채/자본 비율 | 34.7% |
COO 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기